Short Communication: Accumulation of Neutral Lipids in Liver and Aorta of Nef-Transgenic Mice

AIDS Research and Human Retroviruses

Volumn 33, Issue 1, 2017, Pages 57-60

  Pushkarsky, Tatiana ^a   Shilov, Evgeny ^b   Kruglova, Natalya ^b   Naumann, Ronald ^c   Brichacek, Beda ^a   Jennelle, Lucas ^a,g   Sviridov, Dmitri ^d   Kruglov, Andrei ^b,e,f   Nedospasov, Sergei A ^b,e,f   Bukrinsky, Michael ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^f German Rheumatism Research Center   (Germany)

^g UNIVERSITY OF VIRGINIA   (United States)

Author keywords

cholesterol efflux; HIV 1; lipid droplets; Nef

Indexed keywords

CHOLESTEROL; FAT DROPLET; LIPID; NEF PROTEIN; NEUTRAL LIPID; RNA; UNCLASSIFIED DRUG; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HETEROZYGOTE; IN VITRO STUDY; LIPID LIVER LEVEL; LIPID STORAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAINING; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE MOUSE; ANIMAL; AORTA; BIOSYNTHESIS; C57BL MOUSE; CYTOCHEMISTRY; GENETICS; LIVER; PATHOLOGY;

ANIMALS; AORTA; HISTOCYTOCHEMISTRY; LIPIDS; LIVER; MICE, INBRED C57BL; MICE, TRANSGENIC; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; STAINING AND LABELING;

EID: 85009089728     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2016.0128     Document Type: Article

References (17)

1. Escaut L, Monsuez JJ, Chironi G, et al.: Coronary artery disease in HIV infected patients. Intensive Care Med 2003;29:969-973.
2. Neumann T, Woiwoid T, Neumann A, et al.: Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients: Part I. Differences due to the acquisition of HIV-infection. Eur J Med Res 2003;8:229-235.
3. Patel AA, Budoff MJ: Coronary artery disease in patients with HIV infection. Am J Cardiovasc Drugs 2015;15:81-87.
4. Troseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD: Microbial translocation and cardiometa-bolic risk factors in HIV infection. AIDS Res Hum Ret-roviruses 2014;30:514-522.
5. Boccara F, Lang S, Meuleman C, et al.: HIV and coronary heart disease: Time for a better understanding. J Am Coll Cardiol 2013;61:511-523.
6. Mujawar Z, Rose H, Morrow MP, et al.: Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol 2006;4:e365.
7. Jennelle L, Hunegnaw R, Dubrovsky L, et al.: HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chap-erone calnexin. J Biol Chem 2014;289:28870-28884.
8. Cui HL, Ditiatkovski M, Kesani R, et al.: HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis. FASEB J 2014;28:2828-2839.
9. Asztalos BF, Mujawar Z, Morrow MP, et al.: Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis 2010;202:614-623.
10. Khan MB, Lang MJ, Huang MB, et al.: Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Abeta1-42 secretion in SH-SY5Y neural cells. J Neurovirol 2016;22:179-190.
11. Araki K, Araki M, Miyazaki J, Vassalli P: Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci U S A 1995;92:160-164.
12. Willimsky G, Blankenstein T: Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 2005;437:141-146.
13. Shugars DC, Smith MS, Glueck DH, Nantermet PV, Seillier-Moiseiwitsch F, Swanstrom R: Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol 1993;67:4639-4650.
14. Bobryshev YV, Lord RS: Accumulation of co-localised unesterified cholesterol and neutral lipids within vacuolised elastin fibres in athero-prone areas of the human aorta. Atherosclerosis 1999;142:121-131.
15. Watanabe H, Shiratori T, Shoji H, et al.: A novel acyl-CoA thioesterase enhances its enzymatic activity by direct binding with HIV Nef. Biochem Biophys Res Commun 1997;238: 234-239.
16. Liu LX, Heveker N, Fackler OT, et al.: Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J Virol 2000;74: 5310-5319.
17. Hunt MC, Solaas K, Kase BF, Alexson SE: Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. J Biol Chem 2002;277:1128-1138.